Paperpal Prime Logo

Breast Cancer : Impact Factor & More

eISSN: 1880-4233pISSN: 1340-6868

Key Metrics

CiteScore
5.9
Impact Factor
< 5
SNIP
1.21
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Breast Cancer

Breast Cancer Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
Overview
Publisher SPRINGER JAPAN KK
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year1993
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Breast Cancer ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Breast Cancer

Clinical outcomes of postoperative radiotherapy with regional nodal irradiation excluding internal mammary lymph nodes in breast cancer: a multi-institutional retrospective analysis.
  • 1 Jul 2026
  • Breast cancer (Tokyo, Japan)
Differences in drug efficacy and prognosis between primary and metastatic sites for de novo stage IV breast cancer: an exploratory analysis of a phase III trial, JCOG1017.
  • 1 Jul 2026
  • Breast cancer (Tokyo, Japan)
Short- and long-term effectiveness of physical activity interventions for women living with and beyond breast cancer: a systematic review and meta-analysis.
  • 1 Jul 2026
  • Breast cancer (Tokyo, Japan)
Evaluation of serum microRNA-9-5p expression and its predicted target genes as potential biomarkers for breast cancer.
  • 1 Jul 2026
  • Breast cancer (Tokyo, Japan)
Prevalence and clinical significance of germline pathogenic variants identified by multigene panel testing in high-risk Japanese patients with breast cancer.
  • 1 Jul 2026
  • Breast cancer (Tokyo, Japan)
Prognosis of patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative, 1-3 node-positive breast cancer meeting the high-risk criteria of the monarchE trial: a comparison between macrometastasis and micrometastasis.
  • 1 Jul 2026
  • Breast cancer (Tokyo, Japan)
Clinical outcomes of postoperative radiotherapy with regional nodal irradiation excluding internal mammary lymph nodes in breast cancer: a multi-institutional retrospective analysis.
  • 1 Jul 2026
  • Breast cancer (Tokyo, Japan)
Differences in drug efficacy and prognosis between primary and metastatic sites for de novo stage IV breast cancer: an exploratory analysis of a phase III trial, JCOG1017.
  • 1 Jul 2026
  • Breast cancer (Tokyo, Japan)
Short- and long-term effectiveness of physical activity interventions for women living with and beyond breast cancer: a systematic review and meta-analysis.
  • 1 Jul 2026
  • Breast cancer (Tokyo, Japan)
Evaluation of serum microRNA-9-5p expression and its predicted target genes as potential biomarkers for breast cancer.
  • 1 Jul 2026
  • Breast cancer (Tokyo, Japan)
Prevalence and clinical significance of germline pathogenic variants identified by multigene panel testing in high-risk Japanese patients with breast cancer.
  • 1 Jul 2026
  • Breast cancer (Tokyo, Japan)
Prognosis of patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative, 1-3 node-positive breast cancer meeting the high-risk criteria of the monarchE trial: a comparison between macrometastasis and micrometastasis.
  • 1 Jul 2026
  • Breast cancer (Tokyo, Japan)

FAQs on Breast Cancer